NanoViricides Inc. | Balance Sheet

Fiscal year is July-June. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
13,923.20
36,696.90
31,467.70
24,162.20
15,099.50
7,081.80
Other Current Assets
598.40
967.30
214.40
219.50
190.20
240.30
Total Current Assets
14,521.60
37,664.20
31,682.20
24,381.60
15,289.60
7,322
Net Property, Plant & Equipment
468.90
5,496.80
11,962.60
11,760.80
11,271.10
10,841.10
Total Investments and Advances
-
1,000.00
-
3.50
-
-
Intangible Assets
417.00
408.30
399.70
391.50
383.20
374.90
Other Assets
1,000.00
-
142.50
96.00
58.90
8.20
Total Assets
16,407.60
44,569.20
44,187.10
36,633.40
27,002.80
18,546.20
ST Debt & Current Portion LT Debt
-
-
-
5,474.70
3,956.20
Accounts Payable
973.80
-
-
-
-
Other Current Liabilities
204.40
1,227.00
600.90
1,269.30
709.40
Total Current Liabilities
1,178.20
1,227.00
600.90
6,744.00
4,665.50
Long-Term Debt
3,468.10
19,973.00
11,467.00
3,133.70
-
Other Liabilities
3,751.60
-
333.30
3,707.50
2,015.40
Total Liabilities
8,397.90
21,199.90
12,401.20
13,585.20
6,680.90
Common Equity (Total)
8,006.70
23,366.10
31,782.30
23,044.10
20,317.60
Total Shareholders' Equity
8,009.70
23,369.30
31,785.90
23,048.20
20,321.90
Total Equity
8,009.70
23,369.30
31,785.90
23,048.20
20,321.90
Liabilities & Shareholders' Equity
16,407.60
44,569.20
44,187.10
36,633.40
27,002.80
Preferred Stock (Carrying Value)
3.00
3.20
3.60
4.10
4.30

About NanoViricides

View Profile
Address
1 Controls Drive
Shelton Connecticut 06484
United States
Employees -
Website http://www.nanoviricides.com
Updated 07/08/2019
NanoViricides, Inc. is a nano-biopharmaceutical company. The company engages in the discovery, development, and commercialization of therapeutics to advance the care of patients suffering from life-threatening viral infections. It intends to manufacture Injectable and Oral FluCide, HIVCide, Nanoviricide Eye Drops, HerpeCide, DengueCide, RabiCide as well as other drugs for pre-clinical animal studies and human clinical studies.